Notch3 and HEY-1 as prognostic biomarkers in pancreatic adenocarcinoma.

Notch3 and HEY-1 as prognostic biomarkers in pancreatic adenocarcinoma.

In order to achieve a better outcome for pancreatic cancer patients, reliable biomarkers are required which allow for improved diagnosis. These may emanate from a more detailed molecular understanding of the aggressive nature of this disease. Having previously reported that Notch3 activation appeare...

Full description

Bibliographic Details
Main Authors: Christopher D Mann, Christopher Bastianpillai, Christopher P Neal, Muhammad M Masood, Donald J L Jones, Friederike Teichert, Rajinder Singh, Elena Karpova, David P Berry, Margaret M Manson
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3514220?pdf=render

Internet

http://europepmc.org/articles/PMC3514220?pdf=render

Similar Items